Dana-farber Cancer Institute

This study tests a targeted therapy called abemaciclib in people whose glioblastoma (a type of brain cancer) has come back. The goal is to see if the drug reaches the tumor and helps slow cancer growth. About 45 adults with recurrent glioblastoma will take the drug before surgery…